Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results
Amgen (NASDAQ:AMGN) will report its Q4 and full year 2020 financial results on Feb. 2, 2021, after the close of U.S. markets.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will report its Q4 and full year 2020 financial results on Feb. 2, 2021, after the close of U.S. markets. Following the announcement, a conference call will be held at 5 p.m. EST featuring CEO Robert A. Bradway and senior management. Investors and the public can access the live audio via Amgen's website. Amgen is dedicated to innovative therapeutics, leveraging advanced human genetics to address serious health issues.
Details
News Market Reaction – AMGN
The recorded move for AMGN in the trading session of this news was -2.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
THOUSAND OAKS, Calif., Jan. 28, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2020 financial results on Tuesday, Feb. 2, 2021, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 5 p.m. EST. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media)
Arvind Sood, 805-447-1060 (investors)
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-fourth-quarter-and-full-year-financial-results-301217691.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.